Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exero Medical’s pivotal international multi-center study of its xBar device began enrolling patients in Israel and the US in early/mid 2024. The device has monitored over twenty patients recovering from colorectal surgery with ongoing data collection. The company aims to demonstrate that its implantable biodegradable wireless sensor can provide actionable data to detect life-threatening complications such as anastomotic leaks earlier than current standard-of-care methods. No published final results yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exero Medical.